Biogen Inc. buy StockNews.com
Start price
28.09.25
/
50%
€116.65
Target price
28.09.26
-
Performance (%)
24.09%
Price
15.01.26
€145.30
Summary
This prediction is currently active. The prediction currently has a performance of 24.09%. This prediction currently runs until 28.09.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -8.931% | -8.931% |
| iShares Core DAX® | 0.336% | 4.366% |
| iShares Nasdaq 100 | 0.541% | 3.170% |
| iShares Nikkei 225® | 4.048% | 6.727% |
| iShares S&P 500 | 0.795% | 3.281% |
Comments by StockNews_com for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for BIIB provided by MarketBeat